The splicing factor HNRNPH1 regulates Circ-MYOCD back-splicing to modulate the course of cardiac hypertrophy.
10.12122/j.issn.1673-4254.2025.03.16
- Author:
Rui CAI
1
;
Zhuo HUANG
1
;
Wenxia HE
2
;
Tianhong AI
2
;
Xiaowei SONG
2
;
Shuting HU
1
Author Information
1. School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
2. Department of Cardiology,First Affiliated Hospital,Naval Medical University, Shanghai 200433, China.
- Publication Type:Journal Article
- Keywords:
HNRNPH1;
back-splicing;
cardiac hypertrophy;
circular RNA;
splicing factors
- MeSH:
Animals;
Rats;
RNA, Circular/genetics*;
Cardiomegaly/metabolism*;
Myocytes, Cardiac/metabolism*;
Heterogeneous-Nuclear Ribonucleoprotein Group F-H/metabolism*;
Cell Line;
RNA Splicing;
Angiotensin II;
RNA-Binding Proteins
- From:
Journal of Southern Medical University
2025;45(3):587-594
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To explore the mechanism of Circ-MYOCD back-splicing and its regulatory role in myocardial hypertrophy.
METHODS:Sanger sequencing and RNase R assays were performed to verify the circularity and stability of Circ-MYOCD, whose subcellular distribution was determined by nuclear-cytoplasmic fractionation. Bioinformatics analysis and mass spectrometry from pull-down assays were conducted to predict the RNA-binding proteins (RBPs) interacting with Circ-MYOCD. In rat cardiomyocytes H9C2 cells, the effects of HNRNPH1 and HNRNPL knockdown and overexpression on Circ-MYOCD back-splicing were evaluated. In a H9C2 cell model of angiotensin II (Ang II)-induced myocardial hypertrophy, the expression of HNRNPH1 was detected, the effects of HNRNPH1 knockdown and overexpression on progression of myocardial hypertrophy were assessed, and the regulatory effect of HNRNPH1 on Circ-MYOCD back-splicing was analyzed.
RESULTS:Sanger sequencing confirmed that the junction primers could amplify the correct Circ-MYOCD sequence. RNase R and nuclear-cytoplasmic fractionation assays showed that Circ-MYOCD was stable and predominantly localized in the cytoplasm. Bioinformatics analysis and mass spectrometry from the Circ-MYOCD pull-down assay identified HNRNPH1 and HNRNPL as the RBPs interacting with Circ-MYOCD. In H9C2 cells, HNRNPH1 knockdown significantly enhanced while its overexpression inhibited Circ-MYOCD back-splicing; HNRNPH1 overexpression obviously increased the expressions of myocardial hypertrophy markers ANP and BNP, while its knockdown produced the opposite effect. In Ang II-induced H9C2 cells, which exhibited a significant increase of HNRNPH1 expression and increased expressions of ANP and BNP, HNRNPH1 knockdown obviously increased Circ-MYOCD expression, decreased MYOCD expression and lowered both ANP and BNP expressions.
CONCLUSIONS:HNRNPH1 regulates Circ-MYOCD back-splicing to influence the progression of myocardial hypertrophy.
